CoA Protocols by LC-MS/MS, AAS and GC-MS/MS.
Development of a murine model (C57BL/6) of autoimmune encephalomyelitis for the evaluation of different formulations and murine model (C57BL/6 and Balb/C) for evaluation of formulations on inflammatory diseases.
Protocol for the bioavailability evaluation in a murine model.
Certification in Good Clinical Practices (GCP) for the researchers of the company.
Agreement with international CRO for the cosmetic effectiveness evaluation of formulations prepared with SA-μ technology®.
Development of clinical trials reported to the WHO database.
Main Study Areas
“Neuropsychological functioning in healthy adults- a pilot study for pharmacological safety”